. SteinEA. Managing dyslipidemia in the high-risk patient. Am J Cardiol2002; 89 (suppl): 50C–7C.
2.
. MaronDJ, FazioS, LintonMF. Current perspectives on statins. Circulation2000; 101: 207–13.
3.
. NebertDW, RussellDW. Clinical importance of the cytochromes P450. Lancet2002; 360: 1155–62.
4.
. NaranjoCA, BustoU, SellersEM, SandorP, RuizI, RobertsEA, A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
5.
. KantolaT, KivistoKT, NeuvonenPJ. Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther1998; 64: 177–82.
